Gene · 26040
Papers2,649
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,649
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CSF3R mutations and variants in myeloid neoplasms: associated phenotypes, co-mutations, and survival trends. | Haematologica | 2025 | 40637773 | PubTator, text mining | PubMed |
| Germline and somatic genetic landscape of pediatric myelodysplastic syndromes. | Haematologica | 2025 | 40568716 | PubTator, text mining | PubMed |
| Regulatory T cells and their role in allergic disease. | Allergy | 2025 | 40497455 | PubTator, text mining | PubMed |
| Clinical characteristics and prognostic significance of co-mutated SETBP1/GATA2 myeloid neoplasms. | Leuk Res | 2025 | 40482584 | PubTator, text mining | PubMed |
| Myelodysplastic syndrome diagnosed by genetic testing for hereditary cancer: a case report. | NPJ Genom Med | 2025 | 40368914 | PubTator, text mining | PubMed |
| [Dynamic changes in genetic mutations in myelodysplastic neoplasms with progressive disease and leukemic transformation]. | Zhonghua Xue Ye Xue Za Zhi | 2025 | 40355355 | PubTator, text mining | PubMed |
| SOHO State of the Art Updates and Next Questions. Atypical Chronic Myeloid Leukemia: Pathogenesis, Diagnostic Challenges, and Therapeutic Strategies. | Clin Lymphoma Myeloma Leuk | 2025 | 40288921 | PubTator, text mining | PubMed |
| Correction to "The Impact of SETBP1 Mutations in Neurological Diseases and Cancer". | Genes Cells | 2025 | 40254817 | PubTator, text mining | PubMed |
| SOHO State of the Art Updates and Next Questions | Atypical Chronic Myeloid Leukemia: Pathogenesis, Diagnostic Challenges and Therapeutic Strategies. | Clin Lymphoma Myeloma Leuk | 2025 | 40189430 | PubTator, text mining | PubMed |
| Acquisition of SETBP1 Mutation During Transformation of Mature Plasmacytoid Dendritic Cell Proliferation to Blastic Plasmacytoid Dendritic Cell Neoplasm in Chronic Myelomonocytic Leukemia. | Int J Lab Hematol | 2025 | 40166840 | PubTator, text mining | PubMed |
| SETBP1-R54P mutation promotes malignant transformation of cadmium-induced 16HBE cells by down-regulating circ_0007095 expression. | Toxicol Sci | 2025 | 40152245 | PubTator, text mining | PubMed |
| Prenatal diagnosis of intellectual disability, autosomal dominant 29 with a nonsense pathogenic variant in SETBP1: a case report and literature review. | Front Genet | 2025 | 40144891 | PubTator, text mining | PubMed |
| Case Report: Prolonged survival in Schinzel-Giedion syndrome featuring megaureter and de novo SETBP1 mutation. | Front Pediatr | 2025 | 40123672 | PubTator, text mining | PubMed |
| Ready for What's Next? The Associations Between Social, Emotional, and Behavioral Skills and Career Adaptability in High School Students. | J Adolesc | 2025 | 40017327 | PubTator, text mining | PubMed |
| [Analysis of SRSF2 Gene Mutation in Patients with Chronic Myelomonocytic Leukemia]. | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2025 | 40017181 | PubTator, text mining | PubMed |
| SET-binding protein 1 (SETBP1) suppresses cell proliferation in estrogen receptor-positive breast cancer. | Breast Cancer | 2025 | 39979691 | PubTator, text mining | PubMed |
| International Expert Opinion on Standard of Care for Patients With Schinzel-Giedion Syndrome: A Modified Delphi Study. | Am J Med Genet A | 2025 | 39967563 | PubTator, text mining | PubMed |
| Monogenic disorders associated with motor speech phenotypes in children and adolescents undergoing clinical exome sequencing. | Genet Med | 2025 | 39931922 | PubTator, text mining | PubMed |
| Significance of Somatic Mutation Profiling in CML Beyond BCR-ABL: A Retrospective Study of the Indian Population. | Indian J Hematol Blood Transfus | 2025 | 39917513 | PubTator, text mining | PubMed |
| A case report of donor cell-derived hematologic neoplasms 9 years after allogeneic hematopoietic cell transplantation. | Oncotarget | 2025 | 39907609 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/26040/papers?page=5